Clinical Trials

366 enrolled

Breast Neoplasms

NCT04714190 2023-12-21

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

351 enrolled

Stomach Neoplasms

NCT02584478 2023-11-08

AL3818

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04938583 2023-10-17

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

54 enrolled

Ovarian Neoplasms

NCT05783921 2023-07-28

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT05753865 2023-03-03

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

454 enrolled

Advanced Breast Cancer

NCT05741021 2023-02-24

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05214976 2022-12-22

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

64 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT05552807 2022-09-23

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

120 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT05235542 2022-08-11

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

130 enrolled

Advanced Malignant Tumors

NCT02970539 2022-02-16

Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers

36 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT05145218 2021-12-08

A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer

405 enrolled

Recurrent Platinum-resistant Ovarian Cancer

NCT04426955 2021-09-16

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

396 enrolled

Esophageal Neoplasms

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

72 enrolled

Other solid neoplasm

Solid Tumor

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

454 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT04555304 2020-09-18

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

81 enrolled

Stomach Neoplasms

NCT04416035 2020-08-31

NSCLC

608 enrolled

Advanced Non-squamous Non-small-cell Lung Cancer

NCT04435652 2020-06-17

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Phase 2/3 Unknown

492 enrolled

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

NCT04405505 2020-05-28

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)

332 enrolled

Triple Negative Breast Neoplasms

NCT04203485 2020-05-08

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

762 enrolled

PD-L1 Positive Non-small Cell Lung Cancer

NCT04000295 2019-10-08

Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer

280 enrolled

Ovarian Neoplasms

NCT04054531 2019-09-10

Study of KN046 With Chemotherapy in First Line Advanced NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04053205 2019-08-12

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

76 enrolled

Advanced Gastric or Gastroesophageal Junction Cancer

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

49 enrolled

Uterine Cervical Neoplasms

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

21 enrolled

Advanced Gastric Cancer

NCT03792074 2019-01-03

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

560 enrolled

Non-squamous Cell Non-small Cell Lung Cancer

NCT03763123 2018-12-04

A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.

48 enrolled

Ovarian Neoplasms

NCT03503604 2018-04-20

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

18 enrolled

Other solid neoplasm

Solid Tumors

NCT03282825 2018-01-23

Clinical Study of Decitabine and Paclitaxel Combination Therapy

18 enrolled

Advanced Breast Cancer

NCT03262948 2017-11-13

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

388 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03195569 2017-06-22

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Unknown

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03026881 2017-03-07

A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

24 enrolled

Recurrence, Stomach Neoplasms

NCT02244502 2016-09-21

Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)

31 enrolled

Ovarian Neoplasms

NCT02879097 2016-08-25

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02644863 2016-05-24

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

60 enrolled

Digestive System Neoplasms, Esophageal Neoplasms, Neoplasms

NCT02630264 2015-12-15

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

540 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01764087 2015-05-18

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

60 enrolled

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Neoplasms, Stomach Neoplasms

NCT02435186 2015-05-06

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

100 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT02283489 2014-11-05

Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

180 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01491217 2011-12-13

A Study of Oraxol® in Gastric Cancer Patients

53 enrolled